123 related articles for article (PubMed ID: 1873015)
1. Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact.
Derkx FH; van den Meiracker AH; Fischli W; Admiraal PJ; Man in't Veld AJ; van Brummelen P; Schalekamp MA
Am J Hypertens; 1991 Jul; 4(7 Pt 1):602-9. PubMed ID: 1873015
[TBL] [Abstract][Full Text] [Related]
2. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
Jeunemaître X; Ménard J; Nussberger J; Guyene TT; Brunner HR; Corvol P
Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
4. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
[TBL] [Abstract][Full Text] [Related]
5. Circulating renin Angiotensin system in childhood chronic renal failure: marked increase of Angiotensin-(1-7) in end-stage renal disease.
Simões e Silva AC; Diniz JS; Pereira RM; Pinheiro SV; Santos RA
Pediatr Res; 2006 Dec; 60(6):734-9. PubMed ID: 17065573
[TBL] [Abstract][Full Text] [Related]
6. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
Simões E Silva AC; Diniz JS; Regueira Filho A; Santos RA
J Pediatr; 2004 Jul; 145(1):93-8. PubMed ID: 15238914
[TBL] [Abstract][Full Text] [Related]
7. Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans.
Camenzind E; Nussberger J; Juillerat L; Munafo A; Fischli W; Coassolo P; van Brummelen P; Kleinbloesem CH; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1991 Sep; 18(3):299-307. PubMed ID: 1720828
[TBL] [Abstract][Full Text] [Related]
8. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
10. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
Herlitz H; Palmgren E; Widgren B; Aurell M
Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
[TBL] [Abstract][Full Text] [Related]
11. In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II.
Nussberger J; Brunner DB; Waeber B; Brunner HR
Life Sci; 1988; 42(17):1683-8. PubMed ID: 2835564
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
13. Blunted suppression of plasma renin activity in diabetes.
Gordon MS; Price DA; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):252-6. PubMed ID: 11881033
[TBL] [Abstract][Full Text] [Related]
14. Methodologic problems in plasma renin activity measurements.
Delorme A; Guyene PT; Corvol P; Menard J
Am J Med; 1976 Nov; 61(5):725-30. PubMed ID: 10727
[TBL] [Abstract][Full Text] [Related]
15. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
Laragh JH; Sealey JE
Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man.
Bursztyn M; Gavras I; Tifft CP; Bauer JH; Melby JC; Gavras H
J Hypertens Suppl; 1989 Dec; 7(6):S306-7. PubMed ID: 2698944
[TBL] [Abstract][Full Text] [Related]
17. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
[TBL] [Abstract][Full Text] [Related]
18. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Bohlender J; Bader M; Ménard J; Nussberger J
J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the renin decrease during hypoxia is adenosine mediated in conscious dogs.
Höhne C; Krebs MO; Boemke W; Arntz E; Kaczmarczyk G
J Appl Physiol (1985); 2001 May; 90(5):1842-8. PubMed ID: 11299275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
